substance P, Pro(9)-

Substance P, Pro(9)- is a specialized peptide derivative belonging to the tachykinin family, designed to facilitate advanced research into neuropeptide signaling and receptor interactions. As a modified form of the well-known neuropeptide substance P, this compound features a proline substitution at the ninth position, which can alter its receptor affinity, metabolic stability, and biological activity. The unique structural attributes of Substance P, Pro(9)- make it a valuable tool for dissecting the nuanced roles of tachykinins in both central and peripheral nervous systems. Researchers benefit from its capacity to serve as a functional analog or antagonist, enabling the exploration of peptide-receptor dynamics, signaling cascades, and molecular mechanisms underlying neuropeptide-mediated processes. Its application spans a diverse range of scientific disciplines, including neurobiology, pharmacology, immunology, and cell signaling, making it an essential resource for laboratories aiming to push the boundaries of peptide research.

Neuroreceptor Binding Studies: Substance P, Pro(9)- is extensively employed in neuroreceptor binding assays to elucidate the specificity and affinity of tachykinin receptors, particularly the neurokinin-1 (NK1) receptor. By introducing the Pro(9) substitution, researchers can investigate how structural modifications impact ligand-receptor interactions, helping to map critical binding domains and identify key amino acid residues responsible for receptor selectivity. This approach is instrumental in advancing our understanding of neuropeptide-receptor dynamics and can guide the rational design of novel analogs with tailored pharmacological profiles. Signal Transduction Research: In the context of cellular signaling, this peptide analog provides a powerful means to probe downstream events following receptor activation. By comparing the signaling pathways triggered by the modified peptide versus native substance P, scientists can delineate the effects of structural changes on G-protein coupled receptor (GPCR) activation, second messenger production, and gene expression patterns. Such studies are vital for unraveling the molecular basis of tachykinin-mediated cellular responses and for identifying potential points of pharmacological intervention. Pain Pathway Investigation: The involvement of substance P and its analogs in nociceptive pathways is well established. Substance P, Pro(9)- serves as a valuable tool for dissecting the role of tachykinins in pain transmission and modulation. By utilizing this compound in in vitro and ex vivo models, researchers can assess its impact on neuronal excitability, neurotransmitter release, and synaptic plasticity. These insights contribute to a deeper understanding of the complex mechanisms governing pain signaling and the development of new strategies for studying pain modulation. Inflammation Mechanism Elucidation: The role of substance P derivatives in inflammatory processes is another area of active investigation. This analog can be used to evaluate the peptide's influence on immune cell activation, cytokine production, and vascular permeability. By comparing its effects to those of the native peptide, scientists gain insight into how structural modifications may alter pro-inflammatory or anti-inflammatory activities, thereby informing the development of targeted research models for inflammation. Neurodegenerative Disease Modeling: Research into neurodegenerative diseases often leverages substance P analogs to model the dysregulation of neuropeptide signaling observed in pathological states. Substance P, Pro(9)- can be incorporated into cellular or animal models to explore its effects on neuronal survival, synaptic integrity, and glial cell function. These studies are critical for identifying the contributions of altered tachykinin signaling to disease progression and for uncovering new avenues for basic research.

Behavioral Neuroscience: In behavioral neuroscience, substance P analogs are used to study the influence of neuropeptide signaling on behavior, emotion, and stress responses. The Pro(9) variant enables researchers to assess how subtle changes in peptide structure affect behavioral phenotypes in experimental models, shedding light on the complex interplay between neurochemical signaling and behavior. Through these diverse applications, Substance P, Pro(9)- continues to empower researchers to unravel the intricate roles of neuropeptides in health and disease, driving innovation and discovery across multiple fields of scientific inquiry.

1. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

3. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function